Pcas SA
PAR:PCA

Watchlist Manager
Pcas SA Logo
Pcas SA
PAR:PCA
Watchlist
Price: 8 EUR Market Closed
Market Cap: 109.9m EUR
Have any thoughts about
Pcas SA?
Write Note

Pcas SA
Equity Earnings Affiliates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pcas SA
Equity Earnings Affiliates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Equity Earnings Affiliates CAGR 3Y CAGR 5Y CAGR 10Y
Pcas SA
PAR:PCA
Equity Earnings Affiliates
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sartorius Stedim Biotech SA
PAR:DIM
Equity Earnings Affiliates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurofins-Cerep SA
PAR:ALECR
Equity Earnings Affiliates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pcas SA
Glance View

Market Cap
109.9m EUR
Industry
Life Sciences Tools & Services

PCAS SA engages in the development, manufacture, and sale of chemicals. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The firm operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.

PCA Intrinsic Value
13.75 EUR
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Pcas SA's Equity Earnings Affiliates?
Equity Earnings Affiliates
0 EUR

Based on the financial report for Jun 30, 2023, Pcas SA's Equity Earnings Affiliates amounts to 0 EUR.

Back to Top